News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-01-10 5:1:43 am European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation PRNewsWire
2023-12-27 8:9:0 am FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras Zacks
2023-12-20 8:1:23 am Mirati Therapeutics Inc EVP & Chief Scientific Officer Jamie Christensen Sells 2,387 Shares GuruFocus.com
2023-12-15 4:5:49 am Insider Sell Alert: EVP Benjamin Hickey Sells Shares of Mirati Therapeutics Inc (MRTX) GuruFocus.com
2023-12-12 10:8:38 am Billionaire Joe Lewis Keeps Trading Stocks Behind US Insider-Trading Charges Bloomberg
2023-11-10 6:0:0 am UPDATE 1-Mirati's lung cancer drug gets EU's regulatory backing Reuters
2023-11-10 4:41:45 am EU regulators back Mirati's lung cancer drug Reuters
2023-11-10 4:30:0 am Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure PR Newswire
2023-11-07 4:44:0 am Mirati's (MRTX) Q3 Loss Narrows, Sales Miss Expectations Zacks
   

Please consider a small donation if you think this website provides you with relevant information